Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IGKC antibody (AA 1-107) (HRP)

IGKC Reactivity: Human ELISA Host: Rabbit Polyclonal HRP
Catalog No. ABIN7156097
  • Target See all IGKC products
    IGKC (Immunoglobulin kappa Constant (IGKC))
    Binding Specificity
    • 3
    • 2
    • 2
    AA 1-107
    Reactivity
    Human
    Host
    • 10
    • 8
    Rabbit
    Clonality
    • 12
    • 6
    Polyclonal
    Conjugate
    • 14
    • 2
    • 1
    • 1
    This IGKC antibody is conjugated to HRP
    Application
    • 7
    • 5
    • 5
    • 4
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    ELISA
    Cross-Reactivity
    Human
    Purification
    >95%, Protein G purified
    Immunogen
    Recombinant Human Immunoglobulin kappa constant protein (1-107AA)
    Isotype
    IgG
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C,-80 °C
    Storage Comment
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    IGKC (Immunoglobulin kappa Constant (IGKC))
    Alternative Name
    IGKC (IGKC Products)
    Synonyms
    HCAK1 antibody, IGKCD antibody, Km antibody, IGKC antibody, Igk-C antibody, immunoglobulin kappa constant antibody, immunoglobulin kappa constant L homeolog antibody, IGKC antibody, LOC708048 antibody, igkc antibody, igkc.L antibody, Igkc antibody
    Background

    Background: Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:22158414, PubMed:20176268). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268).

    Aliases: IGKCImmunoglobulin kappa constant antibody, Ig kappa chain C region antibody, Ig kappa chain C region AG antibody, Ig kappa chain C region CUM antibody, Ig kappa chain C region EU antibody, Ig kappa chain C region OU antibody, Ig kappa chain C region ROY antibody, Ig kappa chain C region TI antibody

    UniProt
    P01834
You are here:
Support